Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia

American Journal of Pathology

Volumn 156, Issue 3, 2000, Pages 965-976

  Marti, Hugo J H ^a   Bernaudin, Myriam ^b   Bellail, Anita ^b   Schoch, Heike ^a   Euler, Monika ^a   Petit, Edwige ^b   Risau, Werner ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; NITROIMIDAZOLE DERIVATIVE; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; HYPOXIA; HYPOXIC CELL; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033902012     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64964-4     Document Type: Article

References (70)

1. Angiogenesis and stroke
2. Role of angiogenesis in patients with cerebral ischemic stroke
3. Mechanisms of angiogenesis
4. What, if anything, is an angiogenic factor?
5. The biology of vascular endothelial growth factor
6. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors
7. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues
8. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor (VEGF) in C6 glioma cells
9. Regulation of angiogenic growth factor expression by hypoxia, transition metals and chelating agents
10. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
11. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
12. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms
13. VEGF and flt. Expression time kinetics in rat brain infarct
14. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats
15. Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat
16. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat
17. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis
18. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis
19. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
20. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer
21. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
22. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
23. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
24. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia
25. Oxygen(es), and the hypoxia-inducible factor-1
26. Endothelial pas domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
27. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 α and developmentally expressed in blood vessels
28. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development
29. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice
30. Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain
31. TNF-a pretreatment induces protective effects against focal cerebral ischemia in mice
32. A potential role for erythropoietin in focal permanent cerebral ischemia in mice
33. Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
34. Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2a
35. E- And P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis
36. Imaging hypoxia and blood flow in normal tissues
37. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acet amide]
38. Hypoxia-inducible factor-1α is regulated at the post-mRNA level
39. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia
40. Hypoxia-induced brain angiogenesis in the adult rat
41. Angiogenesis in cancer, vascular, rheumatoid and other disease
42. 2 tension
43. 2 tension
44. 2 homeostasis by hypoxia-inducible factor 1α
45. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
46. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT
47. HIF-1α is required for solid tumor formation and embryonic vascularization
48. Defective vascularization of HIF-1α -null embryos is not associated with VEGF deficiency but with mesenchymal cell death
49. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
50. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1α
51. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit
52. Vascular endothelial growth factor (VEGF) and its receptors
53. Cytokines and the nervous system II. Actions and mechanisms of actions
54. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct
55. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes; flt-1, but not flk-1/KDR, is up-regulated by hypoxia
56. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
57. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia
58. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system
59. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro
60. High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis
61. Flk-1, a receptor for vascular endothelial growth-factor (VEGF), is expressed by retinal progenitor cells
62. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
63. Neovasculature and blood-brain barrier in ischemic brain infarct
64. Therapeutic angiogenesis
65. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
66. Angiogenesis and vasculogenesis in treatment of cardiovascular disease
67. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo
68. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia
69. Caspases as treatment targets in stroke and neurodegenerative diseases
70. Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice